肝硬化失代偿新定义探讨
该文指出传统肝硬化失代偿定义仅以临床并发症出现为标志,但未区分不同预后亚组。作者基于观察性研究提出失代偿通过两条路径发生:非急性路径和急性路径(含慢加急性肝衰竭),非急性路径多为首次失代偿,急性失代偿多代表进一步失代偿。
要点
- 传统失代偿定义未区分预后亚组,需细化。
- 失代偿分非急性和急性(含ACLF)两条路径。
- 非急性路径多为首次失代偿,急性失代偿多为进一步失代偿。
核心结论
- 肝硬化失代偿应区分非急性和急性两条路径,以更好反映预后差异。
研究设计与样本
- 基于观察性研究对失代偿临床病程的深入分析。
主要发现
- 失代偿可表现为急性失代偿或缓慢发展的腹水、轻度肝性脑病或黄疸而不需住院。
- 非急性失代偿是首次失代偿最常见路径,急性失代偿多代表进一步失代偿。
临床怎么用
- 临床评估肝硬化失代偿时需区分急性与非急性路径,以指导预后判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
There is a universal agreement that the occurrence of clinical complications, such as ascites, hepatic encephalopathy, gastrointestinal bleeding, and jaundice mark the transition from the compensated to the decompensated stage of cirrhosis. Decompensation is associated with a substantial worsening of patient prognosis and is therefore considered the most important stratification variable for the risk of death. However, this classification is an oversimplification, as it does not discriminate between the prognostic subgroups that characterise the course of decompensation, which depends on the type and number of decompensating events. A deeper insight into the clinical course of decompensated cirrhosis is provided by observational studies characterising acute decompensation (AD), which occurs mostly in patients who have already experienced decompensating events. Decompensation presents as AD in a portion of patients while in many others it presents as a slow development of ascites or mild grade 1 or 2 hepatic encephalopathy, or jaundice, not requiring hospitalisation. Thus, we propose that decompensation of cirrhosis occurs through 2 distinct pathways: a non-acute and an acute (which includes acute-on-chronic liver failure) pathway. Moreover, while non-acute decompensation is the most frequent pathway of the first decompensation, AD mostly represents further decompensation.
引用
- D'Amico G, Bernardi M, Angeli P, et al. Towards a new definition of decompensated cirrhosis. J Hepatol. 2021. PMID: 34157322. doi:10.1016/j.jhep.2021.06.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。